Clinical Trial Update: Male Circumcision for HIV Prevention in Rakai, Uganda [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating male circumcision for HIV prevention in Rakai, Uganda has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Herpes Simplex Virus Type Infection
• Syphilis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Herpesvirus 2, Human | Phase 3 | Status: COMPLETED